What this record means
The record shows that TREVARUM is a cancelled Principal Register trademark owned by Novartis AG, a Swiss corporation, and the cancellation was recorded on Jan 13 2022 after the underlying International Registration was deemed dead. The registration covered pharmaceutical preparations for preventing or treating a wide range of diseases—including nervous, immune, cardiovascular, metabolic, respiratory, musculoskeletal, genitourinary, dermatology, oncology, hematology, transplant, ophthalmology and gastro‑intestinal disorders—under International Class 005, so a similar name used for any of those kinds of medicines would present the closest record‑based concern. The record does not give Novartis control over every possible use of the word “TREVARUM” outside that specific pharmaceutical scope. Because the mark was on the Principal Register, there is no Supplemental Register sequence to explain. The prosecution history contains only routine notifications and the final cancellation notice; no oppositions, cancellations or court actions are visible. I'd treat this as a meaningful concern if you plan to brand a drug or related health product with a similar name.
Informational only - not legal advice.Goods & services
Cl. 005Pharmaceuticals
SECTION 70 - CANCELLED Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics